| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
BioAtla Inc (NASDAQ: BCAB)
BCAB Technical Analysis
5
| As on 9th Jun 2023 BCAB STOCK Price closed @ 3.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.86 & Strong Sell for SHORT-TERM with Stoploss of 11.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BCABSTOCK Price
| Open | 3.72 | Change | Price | % |
| High | 3.78 | 1 Day | -0.05 | -1.35 |
| Low | 3.63 | 1 Week | 0.50 | 15.87 |
| Close | 3.65 | 1 Month | 0.20 | 5.80 |
| Volume | 254326 | 1 Year | -16.32 | -81.72 |
| 52 Week High 20.25 | 52 Week Low 2.13 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BCAB Daily Charts |
BCAB Intraday Charts |
Whats New @ Bazaartrend |
BCAB Free Analysis |
|
|
BCAB Important Levels Intraday
| RESISTANCE | 3.94 |
| RESISTANCE | 3.85 |
| RESISTANCE | 3.79 |
| RESISTANCE | 3.73 |
| SUPPORT | 3.57 |
| SUPPORT | 3.51 |
| SUPPORT | 3.45 |
| SUPPORT | 3.36 |
BCAB Forecast May 2024
| 4th UP Forecast | 23.13 |
| 3rd UP Forecast | 16.88 |
| 2nd UP Forecast | 13.02 |
| 1st UP Forecast | 9.16 |
| 1st DOWN Forecast | -1.86 |
| 2nd DOWN Forecast | -5.72 |
| 3rd DOWN Forecast | -9.58 |
| 4th DOWN Forecast | -15.83 |
BCAB Weekly Forecast
| 4th UP Forecast | 8.31 |
| 3rd UP Forecast | 6.82 |
| 2nd UP Forecast | 5.89 |
| 1st UP Forecast | 4.97 |
| 1st DOWN Forecast | 2.33 |
| 2nd DOWN Forecast | 1.41 |
| 3rd DOWN Forecast | 0.48 |
| 4th DOWN Forecast | -1.01 |
BCAB Forecast2024
| 4th UP Forecast | 39.38 |
| 3rd UP Forecast | 27.92 |
| 2nd UP Forecast | 20.84 |
| 1st UP Forecast | 13.75 |
| 1st DOWN Forecast | -6.45 |
| 2nd DOWN Forecast | -13.54 |
| 3rd DOWN Forecast | -20.62 |
| 4th DOWN Forecast | -32.08 |
BioAtla Inc ( NASDAQ USA Symbol : BCAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BCAB Business Profile
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. It also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. The company was founded in 2007 and is based in San Diego, California. Address: 11085 Torreyana Road, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service